Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1478032

GTEX

7f72f629-fc4f-52b1-b6f9-66f25136ff0f

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • SPERMATOGENESIS+0.301
  • KRAS_SIGNALING_DN+0.267
  • HEDGEHOG_SIGNALING+0.248
  • PANCREAS_BETA_CELLS+0.058
  • APICAL_SURFACE-0.019
  • WNT_BETA_CATENIN_SIGNALING-0.033
  • ESTROGEN_RESPONSE_EARLY-0.064
  • UV_RESPONSE_DN-0.074
  • MYOGENESIS-0.118
  • ESTROGEN_RESPONSE_LATE-0.137

Top 10 suppressed

  • MYC_TARGETS_V1-0.630
  • MTORC1_SIGNALING-0.505
  • ANDROGEN_RESPONSE-0.467
  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.458
  • PROTEIN_SECRETION-0.449
  • OXIDATIVE_PHOSPHORYLATION-0.447
  • ANGIOGENESIS-0.442
  • UNFOLDED_PROTEIN_RESPONSE-0.442
  • MYC_TARGETS_V2-0.441
  • DNA_REPAIR-0.430

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

8 twins match this tumor's tissue · 2 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1334717
brain-umap@2
GTEX0.966
2BS_90B22NGP
brain-umap@2
ATRT0.963
3SRR1432343
brain-umap@2
GTEX0.961
4SRR1466850
brain-umap@2
GTEX0.957
5SRR1406561
brain-umap@2
GTEX0.954
6SRR1336379
brain-umap@2
GTEX0.954
7BS_3P20Q2C3
brain-umap@2
low-grade glioma0.952
8SRR1323130
brain-umap@2
GTEX0.950
9SRR4195666
colon-landscapes@1
0.949
10ERR4976613
breast-umap@18
D0.949

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 4 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
SPERMATOGENESIS0.301Inavolisib— uncovered
KRAS_SIGNALING_DN0.267Remibrutinib— uncovered
HEDGEHOG_SIGNALING0.248Inavolisib— uncovered
PANCREAS_BETA_CELLS0.058Cobimetinib— uncovered